MDRX News and Press, Allscripts Healthcare Solutions Inc. From 03/14/23

Top honors awarded in the 50+ physician category, placed in the top five across all physician group sizes Veradigm ® (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions, announced today that Black Book , a healthcare-centric market research and pu...

Boston, Massachusetts--(Newsfile Corp. - March 7, 2023) - Block & Leviton is investigating Veradigm, Inc. (NASDAQ: MDRX) for potential securities law violations. Investors who have lost money in their Veradigm investment should contact the firm to learn more about how they might recover tho...

ATLANTA, March 02, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Veradigm Inc. (“Veradigm” or the “Company”) (NASDAQ: MDRX) complied with federal securities laws. On February 28, 2023, Veradigm disclosed that it “detected cert...

Boston, Massachusetts--(Newsfile Corp. - March 1, 2023) - Block & Leviton is investigating Veradigm, Inc. (NASDAQ: MDRX) for potential securities law violations. Investors who have lost money in their Veradigm investment should contact the firm to learn more about how they might recover tho...

Veradigm Inc. (NASDAQ: MDRX), announced today that in conjunction with its year-end audit procedures it has detected certain internal control failures related to revenue recognition that have occurred over the prior six quarters, resulting in a mis-statement to reported revenues during those peri...

Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes trading in ...

Pharmaceutical executive Susan Rodriguez and digital health/pharma services entrepreneur Dr. Shih-Yin Ho join Board of Directors Susan Rodriguez and Shih-Yin Ho, MD have been named to the Board of Directors of Veradigm Inc. (NASDAQ: MDRX). With their combined experience in the pharmaceu...

Veradigm ® , Inc. (NASDAQ: MDRX), will report its financial results for the three and twelve months ended December 31, 2022 after the close of the regular stock market hours on Wednesday, March 1, 2023. Veradigm management plans to host a conference call and webcast to discuss the compan...

Veradigm Cardiology and Veradigm Metabolic Registry Data Now Available Through the HealthVerity IPGE Platform Veradigm ® , a leading provider of healthcare data and technology solutions (NASDAQ: MDRX), and HealthVerity ® , a leader in Identity, Privacy, Governance, and...

Veradigm FollowMyHealth customer satisfaction has improved more than any other software solution over the past year, strengthening patient care and experience Veradigm Inc. (NASDAQ: MDRX), announced today that Veradigm FollowMyHealth (formerly FollowMyHealth), a leading mobile-first pat...